AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06470243 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06470243 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Given PO
Study NCT06470243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study NCT04840992 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation
Description: Aerogen Solo
Study NCT05281978 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decrease Sedentary Time + Increase MVPA group
Description: 12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise; personalized step count goals to increase daily volume of physical activity and displacement of sedentary time
Study NCT05281978 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Increase MVPA group
Description: 12 week home-based exercise program to promote engagement of 150 min/week of moderate-vigorous intensity exercise
Study NCT06021353 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: UV fs-Laser
Description: Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery
Study NCT05758727 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: The exercise programme is progressive and has three levels. Each bout of exercise and Tai-chi snacking consists of 5 exercises. Each exercise is performed for one minute with one minute rest in between. For exercise snacking movements (including leg exercise, shoulder exercise, single leg exercise, arm exercise, and ankle exercise), participants are encouraged to complete as many repetitions as possible of that exercise in that minute. For Tai-chi snacking movements (including single leg squat, trunk rotation, single leg stand, hip and knee exercise, and ankle mobility exercise), participants are encouraged to complete repetitions of each exercise at a self-selected pace that is comfortable for them to maintain for the full minute, with the aim being to complete the movements as accurately and smoothly as possible (based on correct posture and proper alignment).
Study NCT04986683 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Brain magnetic resonance imaging
Description: Brain magnetic resonance imaging (MRI) will be done using multiple sequences to evaluate the presence, type, and severity of brain abnormalities in enrolled subjects.
Study NCT04986683 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuro-psychology testing
Description: Participants will undergo age-appropriate neuro-psychology testing to assess motor, language, and other neurocognitive functions potentially affected by drug-resistant epilepsy.
Study NCT06194734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KC1036
Description: KC1036 60mg QD orally, before a meal, continuous administration, 21 days as a cycle
Study NCT06194734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irinotecan
Description: Irinotecan intravenously administered at 130-150 mg/m2 once every 2 weeks
Study NCT06194734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: Docetaxel intravenously administered at 60-75 mg/m2 once every 3 weeks；
Study NCT06194734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: S-1
Description: S-1 orally administered 40-60mg Bid on Day 1 to Day 14 of every 3 weeks, 21 days as a cycle
Study NCT04840992 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Description: Intramuscular administration
Study NCT04840992 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Description: Intramuscular administration
Study NCT04840992 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for Inhalation
Description: Aerogen Solo
Study NCT06021353 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: IR fs-Laser
Description: Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery
Study NCT06021353 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: LASIK
Description: Laser-assisted in situ keratomileusis (LASIK) surgery
Study NCT06301087 — intervention group
Intervention type: DEVICE
Intervention: Web Application
Description: web application for monitoring children's development and postnatal depression of mothers
Study NCT05506878 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NSS-2 BRIDGE
Description: NBD® will be applied to either the right or left ear in the immediate post-operative setting (PACU). Only a trained and certified research member who has completed the necessary training required by the company will place the device. The individual placing the device will not be involved in any follow up of the subject or any data collection as that researcher will be unblinded to the treatment allocation. The patient, nurses, surgeons, and other members of the research team will all remain blinded to the treatment allocation.~Once the device is placed, subjects will be asked to perform a pinch test throughout the duration of their time wearing the device. To perform the pinch test subjects must pinch down on the electrodes and ground to ensure the electrodes are still placed in their designated locations and have not come loose.
Study NCT05506878 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham NSS-2 BRIDGE
Description: Sham NBD® will be applied to either the left or right ear in the immediate post-operative setting (PACU). Only a trained and certified research member who has completed the necessary training required by the company will place the device. The individual placing the device will not be involved in any follow up of the subject or any data collection as that researcher will be unblinded to the treatment allocation. The patient, nurses, surgeons, and other members of the research team will all remain blinded to the treatment allocation.
Study NCT05489406 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DTG DT (6 x 5 mg)
Description: DTG 5mg dispersible tablet
Study NCT05489406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTG DT (6 x 5 mg)
Description: DTG 5mg dispersible tablet
Study NCT05489406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F/TAF TOS (3 x 60/7.5 mg)
Description: 60/7.5 mg TOS emtricitabine/TAF
Study NCT05489406 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: F/TAF TOS (3 x 60/7.5 mg)
Description: 60/7.5 mg TOS emtricitabine/TAF
Study NCT04018508 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: Massage intervention including effleurage, petrissage and energy work/Reiki at a pressure of 2 or less (Walton Pressure Scale)
Study NCT05340244 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational ultrasound exam
Description: Eligible subjects will be enrolled into the study and positioned for their ultrasound exam. Standard clinical practice procedures will be followed using the standard of care device at the site to complete the clinically indicated exams.~After the clinically indicated exam, portions of the TTE and/or TEE exam will be repeated with the investigational ultrasound device.
Study NCT04840992 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular administration
Study NCT05277649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise programme
Description: Performing a programme of warm-up and stretching exercises for the cervico-mandibular region aimed at improving mobility and muscle condition.
Study NCT04852406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Protocol-based management of perioperative antithrombotic therapy
Description: Perioperative antithrombotic therapy is managed according to the latest expert consensus published in the Chinese Medical Journal, 2020.
Study NCT04852406 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Routine management of perioperative antithrombotic therapy
Description: Perioperative antithrombotic therapy is managed according to current routine practice.
Study NCT05120999 — intervention group
Intervention type: DEVICE
Intervention: Train of four measurement
Description: Use of either TetraGraph or TOFScan to measure the neuromuscular blockade
Study NCT04875338 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: plate-rich plasma
Description: 1ml prp (plate-rich plasma to be prepared with the blood taken from the patient on the day of injection), , while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day
Study NCT04875338 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: saline (0.9 NACI)
Description: 1 ml saline (0.9 NACI) while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day
Study NCT04875338 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: betametazon
Description: 1 ml betametazon while the patient is in the supine position, the affected elbow is 90 flexion and neutral rotation, The non-dominant thumb will be placed at the sensitive point in the lateral epicondyle. The injection will be applied to the point with a 23 g needle. After the injection, the subjects will be taught a stretching exercise of the joint extensors of the wrist and fingers. Subjects will be asked to do this exercise five times in one session, two sessions a day
Study NCT04460612 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active IR sock
Description: Subjects will be wearing the infrared socks for 60 minutes
Study NCT04460612 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Active IR sock
Description: Subjects will be wearing the infrared socks for 60 minutes
Study NCT04460612 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo socks
Description: Placebo Socks will be placed on participants feet first for 60 minute
Study NCT04460612 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo socks
Description: Placebo Socks will be placed on participants feet first for 60 minute
Study NCT05300919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement based care
Description: Measurement-based care based on arm.
Study NCT05300919 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Measurement based care
Description: Measurement-based care based on arm.
Study NCT05244018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 tablets
Description: Vitamin D3 tablets 50,000 IU units
Study NCT04645069 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADG126 Mono
Description: ADG126 will be administered as an IV infusion over 30-60 minutes ± 15 minutes.
Study NCT04645069 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADG126-anti PD1
Description: ADG126-toripalimab combination regimen will receive of toripalimab 15 to 30 minutes after the end of the ADG126 infusion
Study NCT04645069 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ADG126-ADG106
Description: ADG126-ADG106 combination regimen will be receive of ADG106 15 to 30 minutes after the end of the ADG126 infusion
Study NCT06249295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oral cryotherapy
Description: The experimental group used drinking water from a water dispenser with regular filter replacement and maintenance, plus a 2x5x7 cm (50 ml) ice lolly module to make ice lollies, and then intervened in the post-surgical period using oral cold therapy (ice lolly in the mouth)
Study NCT05974644 — intervention group
Intervention type: OTHER
Intervention: Registry
Description: The purpose of this registry is to collect and store health information from people who are carriers of the gene known to cause hereditary amyloidosis and those with a confirmed diagnosis of the disease.
Study NCT06466564 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nufairy® Coil embolization system for intracranial aneurysm
Description: Nufairy® Coil embolization system for intracranial aneurysm
Study NCT06466564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nufairy® Coil embolization system for intracranial aneurysm
Description: Nufairy® Coil embolization system for intracranial aneurysm
Study NCT06234644 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Walking Obstacle Course (SWOC)
Description: The Standardized Walking Obstacle Course (SWOC) is a test that allows interaction of a child with environmental demands and obstructions while examining differences in functional ambulation performances. The Group A (experimental group) will receive the treatment with Standardized walking obstacle course (SWOC), the group of 13 participants will receive the treatment. This group will receive therapy session for 45 min, thrice a week for 6 weeks, total sessions will be 18. 45 minutes session time will be divided into 15 min warm up period, 25 minutes of SWOC training and 5 minutes of cool down period.
Study NCT06234644 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Gait Training
Description: Conventional gait training protocol including walking on a treadmill, parallel bar walk, seated marching. The Group B (Control group) will receive the treatment with conventional Gait training, the group of 13 participants will receive the treatment. This group will receive therapy session for 45 min, thrice a week for 6 weeks, total sessions will be 18. 45 minutes session time will be divided into 15 min warm up period, 25 minutes of Conventional gait training and 5 minutes of cool down period.
Study NCT04998318 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pocket Colposcope
Description: Both arms will receive treatment in order to prevent cervical cancer. However, the intervention using the pocket colposcope device will be used on half the enrolled subjects.
Study NCT04998318 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Colposcopy
Description: VIA and VILI as previously described,
Study NCT06343896 — intervention group
Intervention type: OTHER
Intervention: monitorization reliability
Description: evaluation of the use of the integral pulmonary index in the child patient group
Study NCT04988048 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 vaccines
Description: Gam-COVID-Vac Gamaleya National Center for Epidemiology and Microbiology - Russia. Non-replicative viral vector. Multi-dose vial (5 doses in 3 mL) Single-dose vial (1 dose in 0.5 mL). Intramuscular T° less than -18 ° C~BBIBP-CorV Beijing Institute of Biological Products - People's Republic of China. Inactivated viruses. Single-dose vials (1 dose in 0.5 mL) or multi-dose vial (2 doses per vial). Intramuscular T° 2 to 8 ° C~ChAdOx1 nCoV-19 vaccine AZD1222 AstraZeneca-Oxford - United Kingdom. Non-replicative viral vector. Multi-dose vial (10 doses in 5 mL). Intramuscular T°: 2 to 8 ° C~mRNA-1273 or Spikevax Moderna Switzerland GmbH and the National Institute of Allergy and Infectious Diseases (NIAID) of the United States. mRNA. Multi-dose vial (maximum 15 doses per 0.5ml vial). Intramuscular. T°-15 ° to -50 °
Study NCT05244018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D tablets
Description: Vitamin D tablets 5000 units as daily requirements
Study NCT05642013 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early prosthesis reimplantation
Description: Early prosthesis reimplantation, within 16 to 30 days after implants removal
Study NCT05642013 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Retrospective analysis of medical records
Description: Analysis of 50 records of operated patients managed with classical two-stage implant exchange
Study NCT06279130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: botensilimab
Description: Anti cytotoxic T-lymphocyte associated protein-4 (anti-CTLA4)
Study NCT06279130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: balstilimab
Description: Anti programmed cell death protein-1 (anti-PD1)
Study NCT05844631 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Release
Description: One capsule of Release will be taken three times per day for 180 days in combination with the G4LP.
Study NCT06575296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06575296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Study NCT06575296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06089694 — intervention group
Intervention type: DEVICE
Intervention: Enabling Sensor Research Holter Mode feature
Description: The Sensor Research Holter Mode feature within the Crome and Cobalt ICD and CRT-D devices will be enabled for a short period of time at the In-clinic Testing Visit to allow for desired data collection.
Study NCT06295744 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: WBI with SIB delivered over 5 fractions
Study NCT05685095 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical training
Description: Supervised gait training program 3 times a week, 12 weeks
Study NCT05474690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel + Carboplatin + Trastuzumab + Pertuzumab
Description: Subjects who met the inclusion conditions were randomly divided into TCbHP group and ECHP-THP group according to 1:1.~Stratified at randomization by the following factors: T, N, HER2 expression (HER2 protein 3+ vs HER2 protein 2+ but FISH+), and hormone receptor status (HR positive vs HR negative).~TCbHP regimen drug dose: docetaxel 75 mg/m2 + carboplatin (AUC=6) + trastuzumab (first loading dose 8 mg/kg, sequential maintenance dose 6 mg/kg) + pertuzumab Antibiotics (the initial loading dose of 840 mg, and the sequential maintenance dose of 420 mg), every 21 days as a cycle.
Study NCT05474690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Epirubicin + Cyclophosphamide - Docetaxel) + (Trastuzumab + Pertuzumab)
Description: Dosage of ECHP-THP regimen: epirubicin 90mg/m2+cyclophosphamide 600mg/m2 followed by docetaxel 90mg/m2, trastuzumab (first loading dose 8 mg/kg, sequential maintenance dose 6 mg /kg) + Pertuzumab (the initial loading dose of 840 mg, and the sequential maintenance dose of 420 mg), every 21 days as a cycle.
Study NCT05078424 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy
Description: CBT is a well-established, evidence-based intervention frequently used for easing depressive and anxiety symptoms. The intervention will be delivered for 6-7 sessions, each session lasts for 1.5 hours, in the format of a group for a period of 6-7 weeks by frontline social or youth workers trained by professional CBT clinicians. Core treatment components include mood monitoring, emotion education, behavioural activation, emotion cycle/ ABC model, identification of automatic thoughts, and cognitive restructuring. It is designed to improve youths' abilities/ skills in handling their moods to have better emotional management.
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Infloran probiotic
Description: Infloran
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HAC probiotic
Description: HAc probiotic
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Infloran placebo
Description: Infloran placebo
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Infloran placebo
Description: Infloran placebo
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HAC placebo
Description: HAC placebo
Study NCT04774042 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: HAC placebo
Description: HAC placebo
Study NCT05532098 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dry Needling
Description: Dry Needling will be done for the patients with ADD of TMJ in the retrodiscal tissue and superior joint space .
Study NCT05532098 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRP
Description: Patients with ADD are administered with 1ml of PRP into the retrodiscal tissue and the superior joint space. PRP will be prepared by method proposed by Okuda et al., 2003. Reinjection will be given after 2 weeks if required.
Study NCT05051865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab
Description: camrelizumab combined with SHR1020 for advanced melanoma
Study NCT05051865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR1020
Description: camrelizumab combined with SHR1020 for advanced melanoma
Study NCT06575296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO